Health Catalyst, Inc.
Health Catalyst, Inc. (HCAT) Revenue
Annual & quarterly revenue history · segment & region breakdown
HCAT · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsHealth Catalyst, Inc. trailing twelve-month (TTM) revenue is $0.30B, an increase of 1.48% year-over-year from $0.31B in FY2025.
Revenue trend
2025 – 2017 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.31B | +$0.00B | +1.48% |
| 2024-12-31 | $0.31B | +$0.01B | +3.60% |
| 2023-12-31 | $0.30B | +$0.02B | +7.13% |
| 2022-12-31 | $0.28B | +$0.03B | +14.18% |
| 2021-12-31 | $0.24B | +$0.05B | +28.11% |
| 2020-12-31 | $0.19B | +$0.03B | +21.88% |
| 2019-12-31 | $0.15B | +$0.04B | +37.63% |
| 2018-12-31 | $0.11B | +$0.04B | +54.04% |
| 2017-12-31 | $0.07B | — | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Health Catalyst, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Health Catalyst, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Health Catalyst, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HCAT revenue · 4 questionsHCAT's trailing twelve-month (TTM) revenue is $0.30B. That is an increase of 1.48% year-over-year from $0.31B in FY2025.
▸ Source: FMP · Health Catalyst, Inc. SEC filings · GAAP · Health Catalyst, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026